Joyce Tait was invited to give a keynote address at the European Centre for Regulatory Affairs’ 5th Annual Biopharmaceuticals Meeting in Munich.
The event brought together 110 participants from 16 countries to discuss the latest updates and issues on regulatory development of biopharmaceuticals. Joyce gave the opening keynote address on “Regulation and other factors influencing the development of biopharmaceuticals: The innovator’s perspective”.